177 related articles for article (PubMed ID: 36964657)
1. Loading dynamics of one SARS-CoV-2-derived peptide into MHC-II revealed by kinetic models.
Song K; Xu H; Da LT
Biophys J; 2023 May; 122(9):1665-1677. PubMed ID: 36964657
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of peptide loading into major histocompatibility complex class I molecules chaperoned by TAPBPR.
Xu H; Song K; Da LT
Phys Chem Chem Phys; 2022 May; 24(20):12397-12409. PubMed ID: 35575131
[TBL] [Abstract][Full Text] [Related]
3. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
Kropshofer H; Hämmerling GJ; Vogt AB
Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
[TBL] [Abstract][Full Text] [Related]
4. Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection.
Sadegh-Nasseri S; Natarajan S; Chou CL; Hartman IZ; Narayan K; Kim A
Immunol Res; 2010 Jul; 47(1-3):56-64. PubMed ID: 20066513
[TBL] [Abstract][Full Text] [Related]
5. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
[TBL] [Abstract][Full Text] [Related]
6. Characterization of structural features controlling the receptiveness of empty class II MHC molecules.
Rupp B; Günther S; Makhmoor T; Schlundt A; Dickhaut K; Gupta S; Choudhary I; Wiesmüller KH; Jung G; Freund C; Falk K; Rötzschke O; Kühne R
PLoS One; 2011 Apr; 6(4):e18662. PubMed ID: 21533180
[TBL] [Abstract][Full Text] [Related]
7. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
8. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
9. Conformational flexibility of the MHC class I alpha1-alpha2 domain in peptide bound and free states: a molecular dynamics simulation study.
Zacharias M; Springer S
Biophys J; 2004 Oct; 87(4):2203-14. PubMed ID: 15454423
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
Appella E; Padlan EA; Hunt DF
EXS; 1995; 73():105-19. PubMed ID: 7579970
[TBL] [Abstract][Full Text] [Related]
11. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
Afridi S; Hoessli DC; Hameed MW
Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
[TBL] [Abstract][Full Text] [Related]
13. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.
Yin L; Maben ZJ; Becerra A; Stern LJ
J Immunol; 2015 Jul; 195(2):706-16. PubMed ID: 26062997
[TBL] [Abstract][Full Text] [Related]
15. Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
Poluektov Y; George M; Daftarian P; Delcommenne MC
Vaccine; 2021 Apr; 39(15):2110-2116. PubMed ID: 33744048
[TBL] [Abstract][Full Text] [Related]
16. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
Yaneva R; Springer S; Zacharias M
Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
[TBL] [Abstract][Full Text] [Related]
17. Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism.
Doebele RC; Pashine A; Liu W; Zaller DM; Belmares M; Busch R; Mellins ED
J Immunol; 2003 May; 170(9):4683-92. PubMed ID: 12707347
[TBL] [Abstract][Full Text] [Related]
18. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.
Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ
J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705
[TBL] [Abstract][Full Text] [Related]
19. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
Nielsen M; Lundegaard C; Lund O
BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze MS; Wucherpfennig KW
Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
